-
Ruxolitinib in Severe, COVID-19 Patients: A Randomized Phase-II Trial
- Sep 2 2020
- Length: 6 mins
- Podcast
-
Summary
What listeners say about Ruxolitinib in Severe, COVID-19 Patients: A Randomized Phase-II Trial
Average Customer RatingsOverall
Performance
Story